Division of Cardiology, Cedars-Sinai Medical Center, and the Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California.
Am J Cardiol. 2014 Apr 15;113(8):1436-41. doi: 10.1016/j.amjcard.2014.01.420. Epub 2014 Feb 1.
Although randomized trials and observational studies are used as the evidentiary basis of clinical practice guidelines, they are not always in agreement. Limitations in the process of randomization in the former and the selective referral of patients for treatment as a consequence of clinical "risk stratification" in the latter are underappreciated causes for these disagreements. As a result, neither is guaranteed to correctly quantify treatment benefit. This essay reviews the operational differences between these alternative evidentiary sources and shows how these differences can affect individual clinical decisions, population-based practice guidelines, and national health policy. In conclusion, the process of evidence-based medicine can be improved by independent agencies charged with the responsibility to identify and resolve these differences.
尽管随机试验和观察性研究被用作临床实践指南的证据基础,但它们并不总是一致的。前者在随机化过程中的局限性,以及后者由于临床“风险分层”而导致的患者选择性转诊治疗,是这些不一致的被低估的原因。因此,两者都不能保证正确地量化治疗效果。本文回顾了这两种替代证据来源之间的操作差异,并展示了这些差异如何影响个体临床决策、基于人群的实践指南和国家卫生政策。总之,可以通过独立机构来改进循证医学的过程,这些机构负责识别和解决这些差异。